Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AKCEA THERAPEUTICS, INC.

(AKCA)
 SummaryChartsNewsRatingsCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
03/25/2020 03/26/2020 03/27/2020 03/30/2020 03/31/2020 Date
13.05 14.44 13.31 14.7 14.3 Last
233377 320390 280842 245663 156861 Volume
-2.76% +10.65% -7.83% +10.44% -2.72% Change
Company
Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. The Company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. (Ionis). The Company's volanesorsen drug... 
Sector
Pharmaceuticals
Calendar
-
More about the company
All news about AKCEA THERAPEUTICS, INC.
2020IONIS PHARMACEUTICALS  : Akcea Therapeutics - WAYLIVRA, the first and only thera..
AQ
2020IONIS PHARMACEUTICALS  : and Akcea Recognize FCS Awareness Day with Global Commu..
AQ
2020IONIS PHARMACEUTICALS  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
2020Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study ..
AQ
2020IONIS PHARMACEUTICALS  : and Akcea win prestigious Prix Galien Award for TEGSEDI..
AQ
2020IONIS PHARMACEUTICALS  : completes acquisition of Akcea Therapeutics
AQ
2020AKCEA THERAPEUTICS, INC.  : Entry into a Material Definitive Agreement, Notice o..
AQ
2020IONIS PHARMACEUTICALS INC  : Completion of Acquisition or Disposition of Assets,..
AQ
2020AKCEA THERAPEUTICS  : Ionis Pharmaceuticals completes acquisition of Akcea Thera..
PR
2020AKCEA THERAPEUTICS  : WAYLIVRA▼® (volanesorsen), the First and Only Therap..
BU
2020WeissLaw LLP Reminds AKCA and AIMT Shareholders About Its Ongoing Investigati..
PR
2020KASKELA LAW LLC  : Announces Stockholder Investigation of Akcea Therapeutics, In..
PR
2020AKCEA INVESTOR ALERT BY THE FORMER A : Kahn Swick & Foti, LLC Investigates Adequ..
BU
2020Monteverde & Associates PC Announces an Investigation of Akcea Therapeutics, ..
PR
2020AKCEA THERAPEUTICS, INC.  : Entry into a Material Definitive Agreement, Amendmen..
AQ
More news
News in other languages on AKCEA THERAPEUTICS, INC.

- No features available -

More news
Chart AKCEA THERAPEUTICS, INC.
Duration : Period :
Akcea Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
NameTitle
Damien McDevitt Chief Executive Officer & Director
Michael Dennis Price Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
AKCEA THERAPEUTICS, INC.0.00%1 849
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
PFIZER, INC.7.55%221 613
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582